New Diabetes Guidelines: Impact on Eligibility for Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Canada

Posted date: October 31, 2022

Rebecca Bodoarca, MD ∙ Roseanne O. Yeung, MD, MPH ∙ Darren Lau, MD, PhD, FRCPC

Volume 46, Issue 7 p691-698October 2022

This article reviews the impact of new diabetes treatment guidelines on the eligibility for sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in Canada, assessing how the revised criteria affect patient access to these medications. The findings highlight the potential benefits and challenges of the updated guidelines in managing type 2 diabetes. Diabetes Action Canada supported this research by providing access to the NDR and advocating for the inclusion of patient voices and collaborating with stakeholders to improve access to these innovative therapies.

Associated Programs

Digital Health

Using health data to better understand those living with diabetes and transform diabetes self-management.

Using Data to Change Lives

Episode six features Kylie Peacock, a Diabetes Action Canada Patient Partner and Conrad Pow, a Senior Project Manager at Diabetes Action Canada discussing the National Diabetes Repository and how Diabetes Action Canada is using data to change lives.

Using data to improve health care

Episode four discusses how we can use data to improve health care. Guests Devin Cleary and Dr. Alanna Weisman discuss their research projects in this area – in particular how they are trying to improve outcomes for people with type 1 diabetes.

Diabetes Research Connect Launches

National data repository now available to diabetes researchers This week, Diabetes Research Connect, a national, virtual data repository, launched. The data repository, a collaboration between Diabetes Action Canada and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN), aims to enhance diabetes research across Canada and foster partnerships with academic institutions, healthcare providers and patient groups. […]